MRI Contract Agents May Leave Result in Metal Gadolinium Deposits in Brain: Study
The MRI contrast agents like Omniscan appears to leave deposits of gadolinium deep in the brain, according to the findings of a new study.
Tag Archives: GE Healthcare
-
-
GE MRI Magnet Recall Issued Due to Life-Threatening Injury Risk
Thousands of GE MRI systems are being recalled because of a risk of life-threatening injuries that could be caused by ferrous objects left in the MRI when it is activated.
-
GE Resuscitation System Recall Issued Due to Infant Death Risk
GE Healthcare has recalled a number of infant resuscitator systems which the FDA says could cause infant deaths.
-
Gadolinium Contrast Agents May Cause MRI Scan Misdiagnosis: Study
MRI contrasting agents, used to enhance test results, may be distorting them, leading to misdiagnosis of brain disorders, according to Japanese researchers.
-
Defective Keypads Lead to GE Ventilator & Anesthesia Machine Recall
Defective keypads have led to a recall of a number of GE Healthcare ventilators and anesthesia delivery systems because of problems that could put patients at risk.
-
Nephrogenic Systemic Fibrosis Lawsuit Results in $5M Verdict Against GE
An Ohio jury has determined that GE Healthcare failed to provide proper warnings about the potential side effects of its MRI imaging contrast dye, Omniscan, and ordered the company to…
-
GE Infant Warmer Recalled Due to Oxygen Mixer Problems
A recall has been issued for resuscitation systems installed in infant warmers, due to a possible manufacturing error that may reverse the oxygen mixing concentrations, posing a risk of serious…
-
NSF Cases Disappeared Following MRI Contrast Guidelines: Study
Restrictive guidelines put in place on gadolinium-based contrast agents (GBCAs) used during some MRI examinations appear to be working, according to the findings of U.S. researchers, who report that they…
-
GE Healthcare Omniscan Lawsuit Settled on Eve of Trial
The first trial over nephrogenic systemic fibrosis (NSF) from Omniscan, a gadolinium-based MRI contrast agent manufactured by GE Healthcare, was settled in a last minute deal reached the night before…
-
Nephrogenic Systemic Fibrosis Risk With New MRI Contrast To Be Reviewed
The FDA has asked a panel of outside experts to evaluate the risk of nephrogenic systemic fibrosis (NSF) with a new MRI contrasting agent proposed by Bayer AG.